1 |
Vance GH. College of American Pathologists proposal for the oversight of laboratory-developed tests. Arch Pathol Lab Med,2011,135(11):1432-1435.
|
2 |
Schwartz MK. Genetic testing and the clinical laboratory improvement amendments of 1988: present and future. Clin Chem, 1999,45(5):739-745.
|
3 |
Dequeker E, Ramsden S, Grody WW, et al. Quality control in molecular genetic testing. Nat Rev Genet, 2001,2(9):717-723.
|
4 |
Jennings L, Van Deerlin VM, ML Gulley. Recommended principles and practices for validating clinical molecular pathology tests. Arch Pathol Lab Med, 2009,133(5):743-755.
|
5 |
Kaul K, Leonard DG, Gonzalez A, et al. Oversight of genetic testing:an update. J Mol Diagn, 2001,3(3):85-91.
|
6 |
McGovern MM, Benach MO, Wallenstein S, et al. Quality assurance in molecular genetic testing laboratories. JAMA, 1999,281(9):835-840.
|
7 |
Prence EM. A practical guide for the validation of genetic tests. Genet Test, 1999,3(2):201-205.
|
8 |
Guzel O, Guner EI. ISO 15189 accreditation: Requirements for quality and competence of medical laboratories, experience of a laboratory I.Clin Biochem, 2009,42 (4-5):274-278.
|
9 |
Yanikkaya-Demirel G. ISO 15189 accreditation: Requirements for quality and competence of medical laboratories, experience of a laboratory II. Clin Biochem, 2009,42 (4-5):279-283.
|
10 |
Berwouts S, Morris MA, Dequeker E. Approaches to quality management and accreditation in a genetic testing laboratory. Eur J Hum Genet, 2010,18 Suppl 1:S1-S19.
|
11 |
Ferreira-Gonzalez A, Emmadi R, Day SP, et al. Revisiting oversight and regulation of molecular-based laboratory-developed tests: a position statement of the Association for Molecular Pathology. J Mol Diagn, 2014,16(1):3-6.
|
12 |
Allen TC, Hammond ME, Robboy SJ. Quality and the college of american pathologists. Arch Pathol Lab Med, 2011,135(11): 1441.
|
13 |
Louis DN, Virgin HW, Asa SL. "Next-generation" pathology and laboratory medicine. Arch Pathol Lab Med, 2011,135(12): 1531-1532.
|
14 |
Weiss RL. The long and winding regulatory road for laboratorydeveloped tests. Am J Clin Pathol, 2012,138(1):20-26.
|
15 |
Joly Y, Koutrikas G, Tassé AM, et al. Regulatory approval for new pharmacogenomic tests: a comparative overview. Food Drug Law J,2011,66(1):1-24.
|
16 |
Allen TC. Quality: walk the walk. Arch Pathol Lab Med, 2011,135(11):1384-1386.
|
17 |
Mattocks CJ, Morris MA, Matthijs G, et al. A standardized framework for the validation and verification of clinical molecular genetic tests.Eur J Hum Genet, 2010,18(12):1276-1288.
|
18 |
Halling KC, Schrijver I, Persons DL. Test verification and validation for molecular diagnostic assays. Arch Pathol Lab Med,2012,136(1):11-13.
|